Literature DB >> 17955755

Long-term immunity to hepatitis B among a sample of fully vaccinated children in Cairo, Egypt.

F A Shaaban1, A I Hassanin, S M Samy, S I Salama, Z N Said.   

Abstract

We assessed the long-term immunity to hepatitis B among 242 Egyptian children aged 6-12 years who had received a full vaccination course in infancy, and investigated the factors associated with immunity. Only 39.4% of the children had protective (> or = 10 lU/L) hepatitis B surface antibody levels (HBsAb). This proportion decreased with age but the decrease was not statistically significant. The mean level of HBsAb decreased significantly with increasing age (P = 0.026). A significant negative correlation was found between current age and HBsAb levels (r = -0.31, P = 0.041). Age and weight-for-age were found to be significant predictors of non-protective HBsAb levels.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17955755

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN： 1020-3397            Impact factor:   1.628


  9 in total

1.  Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.

Authors:  Iman I Salama; Samia M Sami; Zeinab Nabil Ahmed Said; Manal H El-Sayed; Lobna A El Etreby; Thanaa M Rabah; Dalia M Elmosalami; Amany T Abdel Hamid; Somaia I Salama; Aida M Abdel Mohsen; Hanaa M Emam; Safaa M Elserougy; Amal I Hassanain; Naglaa F Abd Alhalim; Fatma A Shaaban; Samia A Hemeda; Nihad A Ibrahim; Ammal M Metwally
Journal:  World J Hepatol       Date:  2015-10-08

Review 2.  Induced immunity against hepatitis B virus.

Authors:  Zeinab Nabil Ahmed Said; Kouka Saadeldin Abdelwahab
Journal:  World J Hepatol       Date:  2015-06-28

3.  Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents.

Authors:  Heba Elrashidy; Ashraf Elbahrawy; Gamal El-Didamony; Mohamed Mostafa; Nilly M George; Ahmed Elwassief; Abdel-Gawad Saeid Mohamed; Amr Elmestikawy; Mohamed Hanafy Morsy; Alaa Hashim; Mohamed Ali Abdelbasseer
Journal:  Hum Vaccin Immunother       Date:  2013-06-20       Impact factor: 3.452

4.  Viral hepatitis a to e in South mediterranean countries.

Authors:  Sanaa M Kamal; Sara Mahmoud; Tamer Hafez; Runia El-Fouly
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-02-10       Impact factor: 2.576

5.  Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy.

Authors:  Sohair Ismail; Hanan Abdel Hafez; Samar K Darweesh; Kamal Hassan Kamal; Gamal Esmat
Journal:  Ann Gastroenterol       Date:  2014

6.  Immunogenicity of Recombinant Hepatitis B Vaccine Among Routinely Vaccinated Healthy and Chronically Ill Children in Assiut, Upper Egypt.

Authors:  Osama M El-Asheer; Manal M Darwish; Madleen A Abdou; Khaled Saad
Journal:  Gastroenterology Res       Date:  2015-07-22

7.  Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea.

Authors:  Kyeong Hun Lee; Kyu Seok Shim; In Seok Lim; Soo Ahn Chae; Sin Weon Yun; Na Mi Lee; Young Bae Choi; Dae Yong Yi
Journal:  BMC Pediatr       Date:  2017-07-14       Impact factor: 2.125

8.  Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients.

Authors:  Doaa M Elghannam; Rabab M Aly; Enas F Goda; Ehab E Eltoraby; Raghda E Farag
Journal:  Asian J Transfus Sci       Date:  2009-01

9.  Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran.

Authors:  Reza Norouzirad; Abdol Hussein Shakurnia; Mohammad-Ali Assarehzadegan; Amirarsalan Serajian; Mehdi Khabazkhoob
Journal:  Hepat Mon       Date:  2014-01-12       Impact factor: 0.660
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.